Old Web
English
Sign In
Acemap
>
Paper
>
Evidence for synthetic lethality between bevacizumab and chemotherapy in advanced, p53 null endometrial cancers
Evidence for synthetic lethality between bevacizumab and chemotherapy in advanced, p53 null endometrial cancers
2018
A.R. Mallen
V.L. Filiaci
Douglas A. Levine
K. Thiel
C. Aghajanian
X. Meng
Eric J. Devor
Kathleen N. Moore
M. A. Powell
Angeles Alvarez Secord
Krishnansu S. Tewari
David Bender
Ashley Stuckey
J. Fowler
Summer B. Dewdney
Kimberly K. Leslie
Keywords:
Bevacizumab
General surgery
Synthetic lethality
Medicine
Chemotherapy
Internal medicine
Oncology
Gynecology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI
[]